Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders
- 1 December 2000
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 109 (9) , 712-717
- https://doi.org/10.1016/s0002-9343(00)00617-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Antibodies to β2-glycoprotein I—a specific marker for the antiphospholipid syndromeClinical and Experimental Immunology, 1997
- Prevalence and Signification of Antinuclear and Anticardiolipin Antibodies in Patients with EpilepsyThe American Journal of Medicine, 1997
- Neurological Aspects of Antiphospholipid Antibody SyndromeLupus, 1996
- Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosusArthritis & Rheumatism, 1994
- Anticardiolipin Wet Workshop Report:Fifth International Symposium on Antiphospholipid AntibodiesAmerican Journal of Clinical Pathology, 1994
- Immunological Adverse Effects of AnticonvulsantsDrug Safety, 1993
- Systemic Lupus Erythematosus (SLE)-Like Syndromes Associated with Carbamazepine TherapyDrug Safety, 1991
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- BINOMIAL REGRESSION IN GLIM: ESTIMATING RISK RATIOS AND RISK DIFFERENCES1American Journal of Epidemiology, 1986
- Epilepsy: an early symptom of systemic lupus erythematosus.Journal of Neurology, Neurosurgery & Psychiatry, 1985